Patients with an aggressive form of leukaemia, currently ineligible for any type of targeted therapy, may in fact benefit from some of these new drugs, according to new research by Queen Mary University of London.
Jan 9, 2018
0
1
Chemotherapy for one type of leukaemia could be improved by giving patients a drug currently used to treat an unrelated condition, new research shows.
Dec 21, 2017
0
312
New findings by scientists at the University of Southampton could help to predict how people with the most common form of leukaemia will respond to chemotherapy. The findings will help doctors decide which type of treatment ...
Dec 19, 2017
0
6
In patients with acute myeloid leukaemia, cancer cells resist the effects of chemotherapy, many times resulting in disease recurrence and ultimately death. Researchers from Instituto de Medicina Molecular (iMM) João Lobo ...
Dec 13, 2017
0
3
Australian researchers have developed a new risk scoring system for children with leukaemia based on missing DNA fragments or 'microdeletions'. The risk score will allow doctors to better predict the chance of relapse of ...
Dec 1, 2017
0
7
A study has found an unexpected new drug target for acute myeloid leukaemia (AML) that could open new avenues to develop effective treatments against this potentially lethal disease. Researchers from the Wellcome Trust Sanger ...
Nov 27, 2017
0
34
A study has shown that current methods used to determine the correct level of chemotherapy required for each young patient may be improved by looking at the genetic make-up of the child's cancer cells.
Nov 14, 2017
0
79
Brain cancers are the leading disease-related cause of death in Australian children. And survival rates have changed little in decades. As a paediatric oncologist, the worst conversation I can have with my patients or their ...
Nov 9, 2017
0
3
Researchers from the University of Seville, in collaboration with the Genome Damage and Stability Centre of the University of Sussex in the United Kingdom, have recently published a study in the review Nature Communications, ...
Oct 31, 2017
0
0
Until now, there has been no adequate treatment available for the rare and highly aggressive malignant blood disease T-PLL leukaemia. By screening blood samples from patients with haematological diseases, a team of doctors ...
Oct 24, 2017
0
19
